Implementing the protocol of a pilot randomized controlled trial for the recovery-oriented intervention to people with psychoses in two Latin American cities.


Journal

Cadernos de saude publica
ISSN: 1678-4464
Titre abrégé: Cad Saude Publica
Pays: Brazil
ID NLM: 8901573

Informations de publication

Date de publication:
02 05 2019
Historique:
received: 01 06 2018
accepted: 08 03 2019
entrez: 9 5 2019
pubmed: 9 5 2019
medline: 6 2 2020
Statut: ppublish

Résumé

Several Latin American countries have made remarkable strides towards offering community mental health care for people with psychoses. Nonetheless, mental health clinics generally have a very limited outreach in the community, tending to have weaker links to primary health care; rarely engaging patients in providing care; and usually not providing recovery-oriented services. This paper describes a pilot randomized controlled trial (RCT) of Critical Time Intervention-Task Shifting (CTI-TS) aimed at addressing such limitations. The pilot RCT was conducted in Santiago (Chile) and Rio de Janeiro (Brazil). We included 110 people with psychosis in the study, who were recruited at the time of entry into community mental health clinics. Trial participants were randomly divided into CTI-TS intervention and usual care. Those allocated to the intervention group received usual care and, in addition, CTI-TS services over a 9-month period. Primary outcomes include quality of life (WHO Quality of Life Scale - Brief Version) and unmet needs (Camberwell Assessment of Needs) at the 18-month follow-up. Primary outcomes at 18 months will be analyzed by Generalized Estimating Equations (GEE), with observations clustered within sites. We will use three-level multilevel models to examine time trends on the primary outcomes. Similar procedures will be used for analyzing secondary outcomes. Our hope is that this trial provides a foundation for planning a large-scale multi-site RCT to establish the efficacy of recovery-oriented interventions such as CTI-TS in Latin America.

Identifiants

pubmed: 31066775
pii: S0102-311X2019000404001
doi: 10.1590/0102-311X00108018
pmc: PMC6688497
mid: NIHMS1033750
pii:
doi:

Types de publication

Journal Article Randomized Controlled Trial

Langues

eng

Sous-ensembles de citation

IM

Pagination

e00108018

Subventions

Organisme : NIMH NIH HHS
ID : U19 MH095718
Pays : United States

Références

Psychiatr Serv. 2010 Mar;61(3):218-21
pubmed: 20194395
Rev Saude Publica. 2009 Aug;43 Suppl 1:8-15
pubmed: 19669059
Bull World Health Organ. 2010 Nov 1;88(11):815-23
pubmed: 21076562
Psychiatr Serv. 2014 Apr 1;65(4):429-41
pubmed: 24549400
Psychiatr Serv. 2011 Dec;62(12):1470-6
pubmed: 22193795
Ment Health Serv Res. 2003 Dec;5(4):209-21
pubmed: 14672500
Cien Saude Colet. 2011 Dec;16(12):4635-42
pubmed: 22124904
Psychiatry Res. 2003 Nov 1;121(1):31-49
pubmed: 14572622
Schizophr Bull. 2004;30(4):1035-41
pubmed: 15957202
Public Health Rev. 2012;34(2):
pubmed: 25339792
Psychol Med. 1998 May;28(3):551-8
pubmed: 9626712
Int J Ment Health Syst. 2008 Sep 05;2(1):12
pubmed: 18775070
Curr Opin Psychiatry. 2016 Jul;29(4):264-9
pubmed: 27175555
Am J Public Health. 1997 Feb;87(2):256-62
pubmed: 9103106
Br J Psychiatry. 1995 Nov;167(5):589-95
pubmed: 8564313
Int Health. 2013 Mar;5(1):15-8
pubmed: 24029840
Cien Saude Colet. 2015 Oct;20(10):3243-53
pubmed: 26465864
Psychiatr Serv. 2011 Jul;62(7):713-9
pubmed: 21724782
Addiction. 2002 Sep;97(9):1183-94
pubmed: 12199834
Cien Saude Colet. 2011 Dec;16(12):4623-34
pubmed: 22124903
J Prim Prev. 2007 Jul;28(3-4):295-312
pubmed: 17541827
Psychiatr Serv. 2011 Dec;62(12):1463-9
pubmed: 22193794
Schizophr Res. 2000 Mar 16;42(1):67-77
pubmed: 10706987

Auteurs

Franco Mascayano (F)

Mailman School of Public Health, Columbia University, New York. U.S.A.
New York State Psychiatric Institute, New York, U.S.A.

Ruben Alvarado (R)

Instituto de Ciencias de la Salud, Universidad de O'Higgins, Rancagua, Chile.

Howard F Andrews (HF)

Mailman School of Public Health, Columbia University, New York. U.S.A.

Maria Jose Jorquera (MJ)

Facultad de Medicina, Universidad de Chile, Santiago, Chile.

Giovanni Marcos Lovisi (GM)

Instituto de Estudos em Saúde Coletiva, Universidade Federal do Rio de Janeiro, Rio de Janeiro, Brasil.

Flavia Mitkiewicz de Souza (FM)

Instituto de Psiquiatria, Universidade Federal do Rio de Janeiro, Rio de Janeiro, Brasil.

Charissa Pratt (C)

Mailman School of Public Health, Columbia University, New York. U.S.A.

Graciela Rojas (G)

Facultad de Medicina, Universidad de Chile, Santiago, Chile.

Maria E Restrepo-Toro (ME)

Yale School of Medicine, Yale University, New Haven, U.S.A.

Kim Fader (K)

Mailman School of Public Health, Columbia University, New York. U.S.A.

Prakash Gorroochurn (P)

Mailman School of Public Health, Columbia University, New York. U.S.A.

Sandro Galea (S)

School of Public Health, Boston University, Boston, U.S.A.

Catarina Magalhães Dahl (CM)

Instituto de Psiquiatria, Universidade Federal do Rio de Janeiro, Rio de Janeiro, Brasil.

Jacqueline Cintra (J)

Instituto de Estudos em Saúde Coletiva, Universidade Federal do Rio de Janeiro, Rio de Janeiro, Brasil.

Sarah Conover (S)

Silberman School of Social Work, Hunter College, New York, U.S.A.

Maria Soledad Burrone (MS)

Instituto de Ciencias de la Salud, Universidad de O'Higgins, Rancagua, Chile.

Joy Noel Baumgartner (JN)

Global Health Institute, Duke University, Durham, U.S.A.

Robert Rosenheck (R)

Yale School of Medicine, Yale University, New Haven, U.S.A.

Sara Schilling (S)

Instituto de Ciencias de la Salud, Universidad de O'Higgins, Rancagua, Chile.
Facultad de Medicina, Universidad de Chile, Santiago, Chile.

Keli Rodrigues Sarução (KR)

Instituto de Estudos em Saúde Coletiva, Universidade Federal do Rio de Janeiro, Rio de Janeiro, Brasil.

Peter Stastny (P)

Community Access, Inc., New York, U.S.A.

Eric Tapia (E)

Instituto de Ciencias de la Salud, Universidad de O'Higgins, Rancagua, Chile.

Maria Tavares Cavalcanti (MT)

Instituto de Psiquiatria, Universidade Federal do Rio de Janeiro, Rio de Janeiro, Brasil.

Eliecer Valencia (E)

Instituto de Ciencias de la Salud, Universidad de O'Higgins, Rancagua, Chile.

Lawrence H Yang (LH)

Mailman School of Public Health, Columbia University, New York. U.S.A.
College of Global Public Health, New York University, New York, U.S.A.

Ezra Susser (E)

Mailman School of Public Health, Columbia University, New York. U.S.A.
New York State Psychiatric Institute, New York, U.S.A.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH